Gary Ingenito, Chief Med. & Reg. Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 80,000 shares at $16.16 ($1.3M) on 2024-06-05, disclosed to the SEC on 2024-06-07.
Open-market sale of $1.3M CPRX by Chief Med. & Reg. Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2024-11-29 | $545K | — | Filing → |
| CPRX | SELL | 2024-11-22 | $806K | — | Filing → |
| CPRX | SELL | 2024-08-13 | $1.8M | — | Filing → |